Cosmos Pharmaceutical Corp
TSE:3349
Intrinsic Value
COSMOS Pharmaceutical Corp. engages in the operation of drugstores. [ Read More ]
The intrinsic value of one
Cosmos Pharmaceutical Corp
stock under the Base Case scenario is
15 515.91
JPY.
Compared to the current market price of 14 415 JPY,
Cosmos Pharmaceutical Corp
is
Undervalued by 7%.
Cosmos Pharmaceutical Corp's market capitalization is 571.3B JPY.
Cosmos Pharmaceutical Corp stock price is 14 415 JPY.
Cosmos Pharmaceutical Corp stock price (14415 JPY) is 7% less than its Intrinsic Value (15 515.91 JPY).
Cosmos Pharmaceutical Corp stock price (14415 JPY) is 4% less than its DCF Value (15 063.53 JPY). Open DCF Valuation
Cosmos Pharmaceutical Corp stock price (14415 JPY) is 10% less than its Relative Value (15 968.29 JPY). Open Relative Valuation
Cosmos Pharmaceutical Corp has upside potential of 19% compared to the average analyst price target.
Open Wall St Estimates
Cosmos Pharmaceutical Corp's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 10%.
Cosmos Pharmaceutical Corp has positive Free Cash Flow for the last twelve months.
Cosmos Pharmaceutical Corp's ROE (Return on Equity) for the past 12 months is positive and is equal to 11%.
Cosmos Pharmaceutical Corp's Revenue has grown by 14% over the past 12 months.
Cosmos Pharmaceutical Corp has positive three-year average ROIC (Return on Invested Capital): 13%. The company is efficient at using invested capital to generate operating income.
Cosmos Pharmaceutical Corp's Revenue has been growing by 8% per year for the last 3 years.
Cosmos Pharmaceutical Corp's ROIC (Return on Invested Capital) has decreased in the last 3 years from 16% to 10%.
Cosmos Pharmaceutical Corp has positive three-year average ROE (Return on Equity): 14%. The company is efficient at transforming stockholders' equity into net income.
Cosmos Pharmaceutical Corp's Revenue is forecast to grow at a rate of 11% per year over the next 3 years.
Cosmos Pharmaceutical Corp's ROE (Return on Equity) has decreased in the last 3 years from 19% to 11%.
Cosmos Pharmaceutical Corp has positive Gross Profit for the last twelve months.
Cosmos Pharmaceutical Corp has positive Operating Income for the last twelve months.
Cosmos Pharmaceutical Corp has positive Net Income for the last twelve months.
Cosmos Pharmaceutical Corp's long-term assets (436B JPY) exceed its long-term liabilties (215B JPY).
Cosmos Pharmaceutical Corp's short-term liabilties (198B JPY) exceed its short-term assets (132B JPY).
Cosmos Pharmaceutical Corp has negative Net Debt. This means that the company has more cash and short-term investments (30B JPY) than debt (9B JPY).
Cosmos Pharmaceutical Corp's D/E (Debt to Equity) is very low and is equal to 0.04.
Cosmos Pharmaceutical Corp's Altman Z-Score is very high and is equal to 4.44.
Cosmos Pharmaceutical Corp earns more than enough operating income (31B JPY) to safely cover interest payments on its debt (63m JPY).
Valuation Backtest
Cosmos Pharmaceutical Corp
Run backtest to discover the historical profit from buying and selling
Cosmos Pharmaceutical Corp
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Cosmos Pharmaceutical Corp
Balance Sheet Decomposition
Cosmos Pharmaceutical Corp
| Current Assets | 132.1B |
| Cash & Short-Term Investments | 29.7B |
| Receivables | 520m |
| Other Current Assets | 101.8B |
| Non-Current Assets | 304.1B |
| PP&E | 278.6B |
| Intangibles | 511m |
| Other Non-Current Assets | 25B |
| Current Liabilities | 198.3B |
| Accounts Payable | 167.1B |
| Other Current Liabilities | 31.2B |
| Non-Current Liabilities | 17B |
| Long-Term Debt | 8.6B |
| Other Non-Current Liabilities | 8.3B |
Earnings Waterfall
Cosmos Pharmaceutical Corp
|
Revenue
|
900.1B
JPY
|
|
Cost of Revenue
|
-721.7B
JPY
|
|
Gross Profit
|
178.4B
JPY
|
|
Operating Expenses
|
-147.9B
JPY
|
|
Operating Income
|
30.6B
JPY
|
|
Other Expenses
|
-6.5B
JPY
|
|
Net Income
|
24.1B
JPY
|
Free Cash Flow Analysis
Cosmos Pharmaceutical Corp
Profitability Score
Profitability Due Diligence
Cosmos Pharmaceutical Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Cosmos Pharmaceutical Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Cosmos Pharmaceutical Corp's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Score
Cosmos Pharmaceutical Corp's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Cosmos Pharmaceutical Corp
According to Wall Street analysts, the average 1-year price target for
Cosmos Pharmaceutical Corp
is 17 179.86 JPY
with a low forecast of 13 231 JPY and a high forecast of 21 000 JPY.
Shareholder Return
Price
Cosmos Pharmaceutical Corp
| Average Annual Return | 14.64% |
| Standard Deviation of Annual Returns | 31.5% |
| Max Drawdown | -46% |
| Market Capitalization | 571.3B JPY |
| Shares Outstanding | 39 628 858 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Cosmos Pharmaceutical Corp
Country
Industry
Market Cap
Dividend Yield
Description
COSMOS Pharmaceutical Corp. engages in the operation of drugstores. The company is headquartered in Fukuoka, Fukuoka-Ken and currently employs 4,872 full-time employees. The company went IPO on 2004-11-11. The firm offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous goods include baby goods, detergents, insecticides, deodorizers, bath goods, toiletries, cookware, gardening goods, automobile goods and clothing products. General food products include processed food products, daily food products, seasonings, confectionery, non-alcoholic beverages and alcoholic beverages. The company also provides tobacco and others.
Contact
IPO
Employees
Officers
The intrinsic value of one
Cosmos Pharmaceutical Corp
stock under the Base Case scenario is
15 515.91
JPY.
Compared to the current market price of 14 415 JPY,
Cosmos Pharmaceutical Corp
is
Undervalued by 7%.
You don't have any saved screeners yet
